RP
REGENERON PHARMACEUTICALS
REGN· Health Care· BiotechnologyS&P 500
Close · 13/11/2026
955.47
1D
+0.45%52-week range
591.52 – 991.73
Volume
11,65,700.00
Price history
REGN
15/10/2026 to 13/11/2026
O 952.47 H 961.94 L 942.00
1W+5.65%
1M+19.98%
3M+18.55%
6M+36.84%
1Y+40.16%
3Y+16.13%
5Y+56.24%
MAX+49.40%
Fundamentals
as of 13/11/2026- Market cap
- $89.77B
- Shares out
- 93.96M
- P/E (trailing)
- 18.63
- P/E (forward)
- 13.49
- EPS (trailing)
- 51.27
- Dividend yield
- 0.39%
- Beta
- 0.10
- Profit margin
- 28.51%
- P/B
- 2.68
- Return on equity
- 14.38%
SEC financial statements
64 quarterly and 18 annual periods through 30/09/2026.
Details
- Ticker
- REGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
12 filers · 2 on watchlist · 12 buys · 22 sells · ?: 1 · D: 25 · R: 8
- 27/03/2026Alan ArmstrongBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2026Gilbert CisnerosSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/02/2026Julia LetlowBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 18/11/2025Gilbert CisnerosBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2025Rob BresnahanBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 01/04/2025Julie JohnsonSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000